Publications by authors named "Emad A Rakha"

Claim this Profile
M
Molecular and Biological Features of Invasive Lobular Carcinoma: Toward New Treatment Strategies.
Nanaka Ozawa, Erina Takeyama, Honoka Sakai, Ayaka Katayama, Mai Onishi, Emad A Rakha

Ann Surg Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome prediction of oestrogen receptor-positive breast cancer based on a panel of oestrogen receptor-regulated genes.
Shorouk Makhlouf, Nabeelah Almalki, Amera Sheha, Nehal M Atallah, Asmaa Ibrahim, Emad A Rakha

Histopathology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine Neoplasms of the Breast: Evolving Concepts and Reappraisal of Classification.
Emad A Rakha, Hannah Y Wen

Surg Pathol Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challenges.
Emad A Rakha, Puay Hoon Tan, Wendy A Raymond

Histopathology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.
Esha Madan, António M Palma, Vignesh Vudatha, Amit Kumar, Praveen Bhoopathi, Emad A Rakha

Nat Biotechnol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Discordance and Error in Breast Pathology: Causes, Classifications, and Medicolegal Implications.
Emad A Rakha, Cecily M Quinn, Elena Provenzano, Sarah E Pinder, Ian O Ellis

Mod Pathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and clinical significance of the RNA mA methyltransferase complex in breast cancer.
Anna E Harris, Jennifer Lothion-Roy, Rachel L Thompson, Maria Haque, Corinne L Woodcock, Emad A Rakha

NPJ Breast Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keratin 24 Predicts Poor Prognosis in Breast Cancer.
Emad Rakha, Yousif A Kariri, Mansour Alsaleem, Taher A Kariri, Mohammed Alkharaiji, Emad A Rakha

Pathobiology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological Significance of Transcription Factor p73 in Breast Cancers: Protein Expression and Transcriptomic Study.
Ahmed Shoqafi, Asmaa Ibrahim, Ayat Lashen, Michael S Toss, Shatha Alqahtani, Emad A Rakha

Biomedicines· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.
Emad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, Kimberly H Allison, Edi Brogi

Mod Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the zinc-finger transcription factor Osterix (SP7) in invasive breast cancer and its prognostic significance.
Behnaz Saidy, Laura Gull, Andrew G Hacker, Emad A Rakha, Andrew R Green

Cell Oncol (Dordr)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.
Puay Hoon Tan, Ian O Ellis, Kimberly H Allison, Sunil S Badve, Edi Brogi, Emad A Rakha

Histopathology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities`.
Mashael Algethami, Ahmed Shoqafi, Ayat Lashen, Shatha Alqahtani, Jake Spicer, Emad A Rakha

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retesting of oestrogen receptor, progesterone receptor and HER2 status of invasive carcinoma of the breast after neoadjuvant chemotherapy.
Andrew H S Lee, Emad A Rakha, Zsolt Hodi, Areeg Abbas, Ian O Ellis

Histopathology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.
Emad A Rakha, Cecily Quinn, Wendy Raymond, Kimberly H Allison, Sunil S Badve

Mod Pathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear morphological characterisation of lobular carcinoma variants: a morphometric study.
Ayaka Katayama, Shorouk Makhlouf, Michael S Toss, Tetsunari Oyama, Emad A Rakha

Histopathology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell division cycle 6 ​is an independent prognostic biomarker in breast cancer.
Yousif A Kariri, Mansour Alsaleem, Abdulbaqi Al-Kawaz, Bader Y Alhatlani, Nigel P Mongan, Emad A Rakha

Pathology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papilloma virus (HPV) mediated cancers: an insightful update.
Sadaf Khursheed Baba, Shahad Shahdad Eissa Alblooshi, Reem Yaqoob, Shalini Behl, Mansour Al Saleem, Emad A Rakha

J Transl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers.
Ahmed Shoqafi, Reem Ali, Ayat Lashen, Jennie N Jeyapalan, Asmaa Ibrahim, Emad A Rakha

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to the Editor: Reassessing margin standards in breast-conserving therapy.
Emad A Rakha, Cecily Quinn, Stephen Fox, Yazan A Masannat, Andreas Karakatsanis

Eur J Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-positive grade 1 invasive carcinomas of the breast.
Andrew H S Lee, Zsolt Hodi, Areeg Abbas, Ian O Ellis, Emad A Rakha

Histopathology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer.
Lutfi H Alfarsi, Rokaya El Ansari, Busra Erkan, Ali Fakroun, Madeleine L Craze, Emad A Rakha

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Breast Cancer Intra-Tumor Heterogeneity Using Artificial Intelligence.
Ayat G Lashen, Noorul Wahab, Michael Toss, Islam Miligy, Suzan Ghanaam, Emad A Rakha

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer.
Busra Erkan, Skye MacIntyre, Charlotte Brown, Ali Fakroun, Ayat G Lashen, Emad A Rakha

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Tyrosine Kinase 7 (PTK7) in Breast Cancer: A Retrospective Analysis of Tumour Expression and Association with Clinical Outcome.
Kate Lacey, Megan R Greener, Tangkam R Marak, Emad A Rakha, Andrew R Green

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis